Skip to content
healthcare.dev

Orilissa

NDC 0074-0039, Elagolix, tablet, film coated, from AbbVie Inc..

Product NDC
0074-0039
Status
Listed
Labeler
AbbVie Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA210450
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/0074-0039 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ELAGOLIX SODIUM200 mg/1

Pharmacologic classes

Cytochrome P450 2C19 Inhibitors [MoA]; Cytochrome P450 3A Inducers [MoA]; Decreased GnRH Secretion [PE]; Gonadotropin Releasing Hormone Receptor Antagonist [EPC]; Gonadotropin Releasing Hormone Receptor Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
0074-0039-14000740039141 BLISTER PACK in 1 CARTON (0074-0039-14) / 14 TABLET, FILM COATED in 1 BLISTER PACK
0074-0039-56000740039564 BLISTER PACK in 1 CARTON (0074-0039-56) / 14 TABLET, FILM COATED in 1 BLISTER PACK

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/a86757b3-09c5-fd3b-1223-244e94f50a66
  • NADAC price for package 00074003956

    GET /v1/drugs/nadac/00074003956

Use it

Look up 0074-0039 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/0074-0039 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 0074-0039. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.